Skip to content
GLP-1 Scorecard
Menu
Graded #496

Zealthy

Zealthy (legal entity FitRX, LLC, recently renamed to Gronk Inc.) offers compounded semaglutide and tirzepatide via an asynchronous telehealth model.

Visit Zealthy ↗We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$286/mo (starting dose, plus a separate fee, compounded)
Tirzepatide
$351/mo (starting dose, plus a separate fee, compounded)
Coverage
34 states
Brand-name
Compounded only

Weigh Zealthy against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because Zealthy dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value26/100
Dose & formulation64/100
Clinical oversight41/100
Labs & monitoring53/100
Fulfillment66/100
Contract terms41/100

Strengths

  • Serves 34 states — meaningful nationwide footprint
  • Asynchronous model removes friction for patients who don't want a video visit
  • Independent licensed prescribers retain full clinical authority

Where it loses points

  • Active Novo Nordisk false-advertising lawsuit alleging trademark infringement and marketing compounded drugs as FDA-approved alternatives
  • Active DOJ/FTC enforcement alleging undisclosed subscription terms, locked cancellation, and unauthorized health-data sharing
  • Founder previously ran Cerebral, which settled with the FTC in 2024 over similar deceptive practices
  • Recently rebranded to Gronk Inc. amid active enforcement
  • FDA issued this company a warning letter dated 1 September 2025; the letter is public in FDA's warning-letter database

Bottom line — Grade C

Best for: Shoppers who want not currently recommended — listed for transparency and reader awareness only.

Ranked #496 of 499 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Visit Zealthy ↗

Closest on the board

The boards grading nearest Zealthy — the realistic shortlist.

Remi Meds#493

Remi Meds is a DTC compounded-GLP-1 telehealth platform offering per-dose-tier compounded semaglutide and tirzepatide-with-B12, plus NAD+, Sermorelin, and Glutathione add-ons.

Basal Health#494

Basal Health is a national GLP-1 telehealth platform built around a metabolic-medicine framework, positioning GLP-1 therapy as one piece of a five-marker picture — insulin sensitivity, muscle mass, hormonal…

Tablet Health#495

Tablet Health is a DTC telehealth platform offering compounded semaglutide and tirzepatide in both injection and oral forms, with ED and NAD+ wellness lines as well.

OlleveCare#497

OlleveCare is a small virtual-urgent-care storefront that has added a cash-pay weight-management track using compounded semaglutide and tirzepatide, available across 13 listed states (including DC).

Kova#498

Kova is a GLP-1 weight-loss program from LifeTech Apps Inc, a Delaware company, pairing compounded GLP-1 medication with a companion app that tracks weight, protein intake and side effects.

Shape Vantage#499

Shape Vantage is a tirzepatide reseller with a hybrid grey-market profile that does not match the typical compounded-telehealth model.

The 21 boards nearest this one

View full scorecard rankings →

Pricing/verification reflect Zealthy's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Zealthy's site. Not medical advice; see our disclosure.

← Back to the scorecard